Gentian Investments

Gentian maintains offices in Cambridge (Massachusetts), Boston, San Francisco, Tokyo, and Switzerland, indicating a mandate that spans North America, Asia, and Europe. The firm appears to source and invest directly in each of these regions rather than running a centralized investment committee from a single headquarters. This distributed structure is rare among early-stage firms and suggests a localized sourcing model where each office operates with meaningful autonomy.

Gentian focuses on early-stage and startup-phase investing, typically entering at the seed and Series A stages where technology risk has been partially de-risked but institutional venture capital has not yet fully priced the opportunity. The firm does not appear to participate in later-stage growth equity, buyouts, or secondary transactions. Its strategy sits at the inflection point between angel syndicates and large multi-stage venture platforms.

Gentian's capitalization structure is not publicly disclosed. The firm's minimalist public profile and absence of marketing materials suggest it may not actively fundraise in the institutional market, potentially operating with a single LP, a small group of backers, or a founder-funded mandate. Allocators seeking to invest would need to engage directly to determine whether the firm accepts external commitments.

Cambridge, Massachusetts and Boston are adjacent cities that together constitute one of the world's highest-density technology and life sciences clusters, anchored by MIT and Harvard in Cambridge and a deep pool of venture-backed companies across the metro area. Maintaining offices in both may reflect separate deal teams or functional groups — for example, a Cambridge office oriented toward early-stage technology spinouts from academic labs and a Boston office focused on later-seed companies in the downtown financial and biotech corridor.

Gentian's Tokyo office places it within Japan's concentrated but capital-efficient startup market, where deep-tech, robotics, and enterprise software companies often lack the volume of domestic venture capital available in the US or China. A physical presence in Tokyo suggests the firm either originates deals locally for its global portfolio or helps portfolio companies access the Japanese market for commercial partnerships and expansion. Specific portfolio companies in Japan have not been publicly named by the firm.